Compare Humana Inc (HUM) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Nano Dimension Ltd - ADR — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Nano Dimension Ltd - ADR trades at $1.56 (market cap $326.41M). The key difference: Humana Inc is far larger — about 145.9× Nano Dimension Ltd - ADR's market cap, and Humana Inc pays a 0.89% dividend while Nano Dimension Ltd - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Nano Dimension Ltd - ADR for 43 Days on average.
| HUM | NNDM | |
|---|---|---|
Market Cap | $47.61B | $326.41M |
Volume | 1,827,332 | 774,004 |
Sector | Health | Technology |
52-Week High | $409.85 | $2.14 |
52-Week Low | $163.67 | $1.21 |
Typical Hold Time | 53 Days | 43 Days |
Enterprise Value | $54.97B | -$78.43M |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Nano Dimension (NNDM) trades at $1.56, down 0.64% with bearish technical signals. The company shows revenue growth to $102.44M in 2025 but maintains negative profitability with a -135.18% net income margin. Recent strategic actions include cost-cutting initiatives and board restructuring to address cash burn concerns.
Outlook remains challenging with persistent losses despite revenue growth. Investment opportunity exists in the company's cash position and strategic repositioning, but risks include ongoing cash burn, leadership transitions, and competitive pressures in the industrial 3D printing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
